TNF-α blockers are a type of drug employed in the treatment of multiple inflammatory and autoimmune diseases, and are mainly applied in the first-line treatment of rheumatoid arthritis (Hu et al., 2024). The gene discussed is TNF; the disease is autoimmune disease.